Products for Research Use Only

Phytic acid (hexasodium)

CAT: 0804-HY-N0814B-01Size: 1 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-N0814B-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Phytic acid (Inositol hexaphosphate) hexasodium is a phosphorus storage compound of seeds and cereal grains. Phytic acid hexasodium has a strong ability to chelate multivalent metal ions, specially zinc, calcium, iron and as with protein residue. Phytic acid hexasodium inhibits the enzymatic superoxide source xanthine oxidase (XO), and has antioxidative, neuroprotective, anti-inflammatory effects.
CAS Number
34367-89-0
Product Name Alternative
Inositol hexaphosphate (hexasodium) ; SNF472
UNSPSC
12352211
Target
Endogenous Metabolite; Xanthine Oxidase
Type
Natural Products
Related Pathways
Metabolic Enzyme/Protease
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology; Neurological Disease
Assay Protocol
https://www.medchemexpress.com/phytic-acid-hexasodium.html
Solubility
10 mM in DMSO
Smiles
O=P(O)(O[Na])O[C@H]1[C@H]([C@H]([C@@H]([C@H]([C@@H]1OP(O)(O[Na])=O)OP(O)(O[Na])=O)OP(O)(O[Na])=O)OP(O)(O[Na])=O)OP(O)(O[Na])=O
Molecular Formula
C6H12Na6O24P6
Molecular Weight
791.93
References & Citations
[1]Perelló J, et al. SNF472, a novel inhibitor of vascular calcification, could be administered during hemodialysis to attain potentially therapeutic phytate levels. J Nephrol. 2018 Apr;31 (2) :287-296.|[2]Zabirnyk A, et al. SNF472, a novel anti-crystallization agent, inhibits induced calcification in an in vitro model of human aortic valve calcification. Vascul Pharmacol. 2019 Nov-Dec;122-123:106583.
Shipping Conditions
Room temperature
Scientific Category
Natural Products
Clinical Information
Phase 3
Isoform
Human Endogenous Metabolite